Who Holds Citius Pharmaceuticals, Inc. (CTXR)? 43 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 43 holders, $810,022 in total.
Largest holders
The 43 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 215,537 | $130,302 | -12% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 197,364 | $119,405 | +18% | 13F |
| Miller Financial Services LLC | 130,000 | $78,585 | +829% | 13F |
| CITADEL ADVISORS LLC | 124,910 | $75,508 | New | 13F |
| JANE STREET GROUP, LLC | 122,837 | $74,255 | +445% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 77,755 | $47,042 | +0% | 13F |
| BlackRock, Inc. | 69,850 | $42,224 | 0% | 13F |
| NORTHERN TRUST CORP | 62,742 | $37,928 | +43% | 13F |
| XTX Topco Ltd | 59,199 | $35,786 | +178% | 13F |
| Asset Advisory Group, Inc. | 59,011 | $35,672 | +0% | 13F |
| BostonPremier Wealth LLC | 28,000 | $16,926 | New | 13F |
| UBS Group AG | 26,335 | $15,933 | -52% | 13F |
| LPL Financial LLC | 25,445 | $15,381 | +2% | 13F |
| STATE STREET CORP | 23,271 | $14,067 | +0% | 13F |
| Arkadios Wealth Advisors | 20,000 | $12,090 | +0% | 13F |
| TWO SIGMA INVESTMENTS, LP | 17,494 | $10,575 | +33% | 13F |
| Sanctuary Advisors, LLC | 11,810 | $7,139 | New | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,795 | $7,130 | -68% | 13F |
| R Squared Ltd | 11,033 | $6,670 | New | 13F |
| TWO SIGMA SECURITIES, LLC | 10,006 | $6,049 | New | 13F |
| SBI Securities Co., Ltd. | 9,519 | $5,754 | +46% | 13F |
| CHELSEA COUNSEL CO | 4,626 | $2,797 | +0% | 13F |
| Quent Capital, LLC | 4,232 | $2,558 | -1% | 13F |
| IFP Advisors, Inc | 4,183 | $2,529 | -41% | 13F |
| Tower Research Capital LLC (TRC) | 2,724 | $1,647 | -2% | 13F |
| OSAIC HOLDINGS, INC. | 2,575 | $1,543 | -6% | 13F |
| GROUP ONE TRADING LLC | 1,551 | $938 | New | 13F |
| SIMPLEX TRADING, LLC | 1,256 | $759 | New | 13F |
| BARCLAYS PLC | 1,096 | $663 | New | 13F |
| WELLS FARGO & COMPANY/MN | 1,000 | $605 | New | 13F |
| Integrated Wealth Concepts LLC | 1,000 | $605 | New | 13F |
| Luminist Capital LLC | 435 | $263 | New | 13F |
| ASSETMARK, INC | 372 | $225 | +0% | 13F |
| Princeton Global Asset Management LLC | 160 | $97 | +0% | 13F |
| Smallwood Wealth Investment Management, LLC | 120 | $72 | +0% | 13F |
| JPMORGAN CHASE & CO | 120 | $69 | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 107 | $65 | +0% | 13F |
| Arax Advisory Partners | 84 | $51 | New | 13F |
| Federation des caisses Desjardins du Quebec | 80 | $48 | +0% | 13F |
| MORGAN STANLEY | 44 | $27 | -97% | 13F |
| Fairscale Capital, LLC | 42 | $25 | +0% | 13F |
| Virtu Financial LLC | 20,836 | $13 | New | 13F |
| Bogart Wealth, LLC | 4 | $2 | +0% | 13F |
Questions and answers
- How many institutions hold Citius Pharmaceuticals, Inc.?
- 43 managers reported Citius Pharmaceuticals, Inc. on Form 13F for the quarter ended 30 June 2026, against 38 the quarter before.
- Who is the largest institutional holder of Citius Pharmaceuticals, Inc.?
- GEODE CAPITAL MANAGEMENT, LLC, with 215,537 shares worth $130,302 on its 13F for Q2 2026.
- How many institutions bought or sold out of Citius Pharmaceuticals, Inc. in Q2 2026?
- 13 managers reported a new position and 8 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Citius Pharmaceuticals, Inc., Q2 2026", https://app.tamarly.ai/holders/citius-pharmaceuticals, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.